GeneOne Life Science, Inc. (KRX: 011000)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,995.00
-35.00 (-1.72%)
Dec 20, 2024, 3:30 PM KST

GeneOne Life Science Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
159,260222,271553,6511,250,928961,06252,422
Upgrade
Market Cap Growth
-24.55%-59.85%-55.74%30.16%1733.31%-42.48%
Upgrade
Enterprise Value
178,952219,584509,9451,241,186881,34744,235
Upgrade
Last Close Price
1995.002840.007140.0016200.0013850.761414.97
Upgrade
PS Ratio
4.155.5311.3632.3223.161.27
Upgrade
PB Ratio
1.801.993.056.069.762.18
Upgrade
P/TBV Ratio
2.372.003.066.089.822.23
Upgrade
EV/Sales Ratio
4.715.4610.4732.0721.241.07
Upgrade
Debt / Equity Ratio
0.260.150.110.090.180.60
Upgrade
Asset Turnover
0.230.220.210.200.440.82
Upgrade
Inventory Turnover
2.903.233.103.173.543.43
Upgrade
Quick Ratio
0.350.771.663.362.681.19
Upgrade
Current Ratio
0.981.512.163.872.961.62
Upgrade
Return on Equity (ROE)
-58.95%-53.09%-19.67%-10.42%-30.43%-28.50%
Upgrade
Return on Assets (ROA)
-16.86%-16.17%-10.61%-8.88%-12.34%-10.29%
Upgrade
Return on Capital (ROIC)
-19.90%-18.33%-11.79%-10.09%-14.96%-12.86%
Upgrade
Earnings Yield
-46.11%-34.99%-6.89%-1.27%-1.94%-14.53%
Upgrade
FCF Yield
-15.15%-12.30%-12.54%-6.98%-3.34%-7.83%
Upgrade
Buyback Yield / Dilution
-1.93%-0.34%-4.37%-22.98%-88.03%-1.93%
Upgrade
Total Shareholder Return
-1.93%-0.34%-4.37%-22.98%-88.03%-1.93%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.